Logo

Integrated DNA Technologies xGen Exome Research Panel v2

Jan 23, 2020

Integrated DNA Technologies has launched the xGen Exome Research Panel v2. The next-generation sequencing panel offers improved on-target rates and uniformity, increased sample coverage, updated content, and enhanced performance. The retail price is $8 per sample, which IDT said is a reduction of more than 50 percent compared to the previous version. Each of the panel's 415,115 probes are individually synthesized on IDT's newest platform, Gemini, and manufactured for one large synthesis lot to ensure reproducible results and avoid lot-to-lot revalidations. Potential applications for the assays include population studies, rare disease research, and oncology, IDT said.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.